Venlafaxine News and Research

RSS
Venlafaxine is an antidepressant drug that is being evaluated for the treatment of hot flashes in women who have breast cancer.
Switching or adding antidepressants does not exacerbate side effects

Switching or adding antidepressants does not exacerbate side effects

New generation antidepressants may increase risk of adverse outcomes in elderly

New generation antidepressants may increase risk of adverse outcomes in elderly

New antidepressant prescription linked to increased risk of falls in nursing home residents

New antidepressant prescription linked to increased risk of falls in nursing home residents

Dr. Reddy’s launches generic ARICEPT, EFFEXOR XR and FEMARA in the US

Dr. Reddy’s launches generic ARICEPT, EFFEXOR XR and FEMARA in the US

FDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat depressive, anxiety disorder

FDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat depressive, anxiety disorder

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

Study: Dual medications do not hasten recovery from depression

Study: Dual medications do not hasten recovery from depression

New guideline on most effective treatments for diabetic nerve pain

New guideline on most effective treatments for diabetic nerve pain

Prolonged exposure to antidepressants can induce tardive dysphoria

Prolonged exposure to antidepressants can induce tardive dysphoria

Teva fourth quarter net sales increase 16% to record $4.4 billion

Teva fourth quarter net sales increase 16% to record $4.4 billion

Breast cancer patients taking tamoxifen anxious to have CYP2D6 genetic test

Breast cancer patients taking tamoxifen anxious to have CYP2D6 genetic test

Teva third quarter net sales increase 20% to $4.3 billion

Teva third quarter net sales increase 20% to $4.3 billion

Study finds acupuncture can control side effects of cancer treatment

Study finds acupuncture can control side effects of cancer treatment

USFDA approves Sun Pharma's generic Venlafaxine Hydrochloride Extended Release tablets ANDA

USFDA approves Sun Pharma's generic Venlafaxine Hydrochloride Extended Release tablets ANDA

Intellipharmaceutics provides update on generic version of Effexor XR

Intellipharmaceutics provides update on generic version of Effexor XR

Teva launches antidepressant Venlafaxine HCl ER Capsules

Teva launches antidepressant Venlafaxine HCl ER Capsules

FDA grants approval for first generic version of  Effexor XR antidepressant capsules

FDA grants approval for first generic version of Effexor XR antidepressant capsules

Combination therapy for severe depression

Combination therapy for severe depression

FDA approves Teva's generic Effexor XR antidepressant

FDA approves Teva's generic Effexor XR antidepressant

New study finds usage of antidepressants increases risk of miscarriage in pregnant women

New study finds usage of antidepressants increases risk of miscarriage in pregnant women